Letrozole Fempro
| Product/Composition | Letrozole Tablets |
|---|---|
| Strength | 2.5mg |
| Form | Tablet |
| Production Capacity | 10 Million Tablets/Month |
| Packaging | 10 X 10 Tablets / Box |
| Therapeutic use | Hormone Receptor-Positive Breast Cancer |
| Package Insert/Leaflet | Available upon request |
| Brand Name | Fempro |
Fempro contains Letrozole, a non-steroidal aromatase inhibitor used primarily in the treatment of hormone receptor-positive breast cancer. Letrozole works by reducing the production of estrogen in the body, which can help slow or inhibit the growth of estrogen-dependent breast cancer cells.
Fempro Letrozole is commonly used in postmenopausal women for adjuvant treatment of early hormone receptor-positive breast cancer and for advanced or metastatic breast cancer, depending on the treatment plan prescribed by an oncologist. It may also be used in certain fertility-treatment protocols under specialist supervision.
As an aromatase inhibitor, Letrozole blocks the aromatase enzyme responsible for converting androgens into estrogen, thereby lowering circulating estrogen levels.
What is Letrozole?
Letrozole is an aromatase inhibitor belonging to the class of hormonal anticancer medicines. It lowers estrogen production by inhibiting aromatase, an enzyme involved in estrogen synthesis.
Reduced estrogen availability can be particularly important in hormone receptor-positive breast cancer, where estrogen can stimulate cancer-cell growth.
Benefits / Uses of Fempro
Fempro (Letrozole) may be prescribed for:
- Hormone receptor-positive breast cancer
- Adjuvant treatment of early breast cancer in appropriate postmenopausal patients
- Extended adjuvant hormonal therapy in selected patients
- Advanced or metastatic breast cancer
- Certain fertility-treatment protocols when specifically prescribed by a fertility specialist
The exact indication, treatment duration, and combination with other medicines depend on the patient’s condition and treatment protocol.
Dosage Guidelines
The dosage of Fempro should be determined by a qualified healthcare professional.
For breast-cancer treatment, Letrozole is commonly administered once daily, with or without food. Treatment duration varies according to the stage of disease, previous therapy, response to treatment, and the oncologist’s treatment plan.
Patients should:
- Take the medicine at approximately the same time each day.
- Swallow the tablet as directed.
- Avoid changing or stopping treatment without medical advice.
- Follow the prescribed schedule carefully if a dose is missed.
Fempro should be used under appropriate medical supervision.
Wholesale & Supply
Onco India International can support bulk and wholesale pharmaceutical requirements for Letrozole products such as Fempro, subject to product availability, applicable regulations, and destination-country requirements.
For bulk enquiries, distributors, hospitals, pharmacies, pharmaceutical companies, and international buyers can contact the company for product specifications, packaging information, commercial quotations, and supply arrangements.
Buying Fempro Online
Fempro should be purchased only through legitimate and authorized pharmaceutical channels. Since Letrozole is a prescription medicine, buyers should ensure that the product is sourced from a reliable supplier and used according to professional medical advice.
For business and wholesale requirements, buyers should verify product availability, documentation, packaging, and applicable import/export requirements before placing an order.
Reviews
Individual experiences with Letrozole can vary considerably. Some patients may tolerate treatment well, while others may experience effects such as hot flashes, joint or muscle discomfort, fatigue, or changes in bone health.
Patient reviews should not replace advice from an oncologist or other qualified healthcare professional.
Quality Assurance
Quality-assured Letrozole products should be manufactured and packaged according to applicable pharmaceutical quality standards. Appropriate quality-control procedures may include testing of raw materials, manufacturing controls, finished-product testing, packaging verification, and batch documentation.
For international pharmaceutical supply, required documentation and regulatory requirements may vary according to the destination market.
Frequently Asked Questions
What is Fempro used for?
Fempro contains Letrozole and is primarily used as hormonal therapy for certain hormone receptor-positive breast cancers, particularly in postmenopausal women.
What type of medicine is Letrozole?
Letrozole is a non-steroidal aromatase inhibitor and hormonal anticancer medicine.
How does Fempro work?
Fempro reduces estrogen production by inhibiting the aromatase enzyme. Lower estrogen levels can help slow the growth of estrogen-dependent breast cancer cells.
Is Fempro a chemotherapy medicine?
No. Letrozole is classified as hormonal therapy, not conventional cytotoxic chemotherapy.
Can Letrozole be used for fertility treatment?
Yes. Letrozole is also used in certain fertility-treatment protocols to stimulate ovulation, but this use should be managed by an appropriately qualified fertility specialist.
What are common side effects of Letrozole?
Possible effects include hot flashes, sweating, joint or muscle pain, fatigue, headache, nausea, and changes in bone mineral density. Individual responses vary.
How long is Letrozole treatment continued?
Treatment duration depends on the cancer type, stage, previous hormonal treatment, recurrence risk, response, and the treating oncologist’s plan.
Can Fempro be stopped suddenly?
Patients should not stop Letrozole without consulting their healthcare professional, even if they feel well.
Conclusion
Fempro (Letrozole) is an aromatase inhibitor used primarily as hormonal therapy for appropriate patients with hormone receptor-positive breast cancer. By reducing estrogen production, Letrozole can help control estrogen-dependent cancer growth. It may also have specialist-directed applications in fertility treatment. Because treatment decisions depend on cancer characteristics and patient-specific factors, Fempro should be used under qualified medical supervision.



